(Q50557593)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Henrik Gréen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Per Damkier

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Werner Vach

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Kim Brosen

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Flemming Nielsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

14

M O Karlsson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

C Brasch-Andersen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

M Mirza

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

R S Pedersen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

K Skougaard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

J Wihl

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

N Keldsen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

L E Friberg

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

C Peterson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

6 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

113-120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20368717%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/tpj.2010.19

30 January 2020

exact match

0 references

cites work

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Non-synonymous single nucleotide alterations found in the CYP2C8 gene result in reduced in vitro paclitaxel metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Identification of functionally variant MDR1 alleles among European Americans and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Measurement of paclitaxel in biological matrices: high-throughput liquid chromatographic-tandem mass spectrometric quantification of paclitaxel and metabolites in human and dog plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Quantitation of Cremophor EL in human plasma samples using a colorimetric dye-binding microassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

A New Statistical Method for Haplotype Reconstruction from Population Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

A "silent" polymorphism in the MDR1 gene changes substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Imputation-based analysis of association studies: candidate regions and quantitative traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Comparison of two types of population pharmacokinetic model structures of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Quantitative effect of gender, age, liver function, and body size on the population pharmacokinetics of Paclitaxel in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

Pharmacogenetic pathway analysis of docetaxel elimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19

The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.19